Stay updated on Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now indicates that no longer looking for participants, signaling that enrollment has ended. New navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment heading was standardized, and the page revision was bumped to v3.6.0.SummaryDifference0.2%

- Check16 days agoChange DetectedThe site revision label was updated from v3.5.4 to v3.5.5, signaling a new version of the page template. No study-specific content or functionality changes are indicated.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag has been updated to Revision: v3.5.4, replacing the previous v3.5.3. This indicates a new version of the page in the site's revision history.SummaryDifference0.0%

- Check52 days agoChange DetectedUpdated the location entry from Malmo, Sweden, 20502 to Malmö, Sweden, 20502 to reflect the correct spelling of the city name.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s revision/version label has been incremented from v3.5.2 to v3.5.3, indicating a site/update release rather than any change to the study information.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision tag updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Safety & Antiviral Activity in Severe COVID-19 Clinical Trial page.